Article info

Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme

Authors

  1. Correspondence to Professor Frank G Holz, Department of Ophthalmology, University of Bonn, Ernst-Abbe-Strasse 2, Bonn 53127, Germany; Frank.Holz{at}ukb.uni-bonn.de
View Full Text

Citation

Holz FG, Bandello F, Gillies M, et al
Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme

Publication history

  • Received March 11, 2013
  • Revised May 29, 2013
  • Accepted June 17, 2013
  • First published July 13, 2013.
Online issue publication 
July 29, 2016

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.